EORTC partners with Pierre Fabre to support patients with stage 2 melanoma

[News]

European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients with resected Stage 2 BRAF-mutant melanoma.

More... (https://www.news-medical.net/news/20210629/EORTC-partners-with-Pierre-Fabre-to-support-patients-with-stage-2-melanoma.aspx)